MedTrace Logo

Pelvic Exenteration and Laterally Extended Pelvic Resection

NCT06278610 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 85

Last updated 2024-05-21

No results posted yet for this study

Summary

Growing evidence in literature is supporting the role of ultrasound scan (US) as accurate tool in diagnosis and staging of gynecologic cancers. In particular, different studies demonstrated the accuracy of US in assessing endometrial, cervical, and ovarian cancer in the primary setting. However, the number of studies investigating the role of US in the recurrent setting is limited. Moreover, there is no evidence in literature exploring the role of US in laterally-extended pelvic recurrences from gynecologic cancer, where the Magnetic Resonance Imaging (MRI) scan is still considered the most accurate tool.

Conditions

  • Gynecologic Cancer
  • Surgical Procedure, Unspecified

Interventions

DIAGNOSTIC_TEST

PELVIC EXENTERATION

PELVIC EXENTERATION

Sponsors & Collaborators

  • Fondazione Policlinico Universitario Agostino Gemelli IRCCS

    lead OTHER

Principal Investigators

  • ANTONIA CARLA TESTA, PROF · Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Eligibility

Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-11-19
Primary Completion
2024-12-30
Completion
2025-01-31

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06278610 on ClinicalTrials.gov